Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Kroon

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The Netherlands Journal of Medicine|July 1, 1997
LDL-cholesterol lowering and atherosclerosis--clinical benefit and possible mechanisms: an updateA A Kroon, A F Stalenhoef
Journal of Cardiovascular Pharmacology|September 10, 1998
Hypertension and the development of heart failureP W de Leeuw, A A Kroon
The Netherlands Journal of Medicine|January 8, 2004
Who should be taking the blood pressure?P W de Leeuw, A A Kroon
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
Fixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertensionP W de Leeuw, A A Kroon
Acta Clinica Belgica|January 30, 2004
Management of hypertensionP W de Leeuw, A A Kroon
Journal of Internal Medicine|December 1, 1991
N-acetylcysteine and serum concentrations of lipoprotein(a)A A Kroon, P N Demacker, A F Stalenhoef
Cardiologia (Rome, Italy)|November 22, 1997
Aggressive lipid lowering treatment in coronary atherosclerosisA F Stalenhoef, A A Kroon, W R Aengevaeren
Annals of Internal Medicine|December 15, 1996
Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery diseaseA A Kroon, W N van Asten, A F Stalenhoef
Nederlands Tijdschrift Voor Geneeskunde|April 12, 2008
[Practical questions related to self-measurement of blood pressure]W J Verberk, A A Kroon, P W de Leeuw
Atherosclerosis|October 19, 1999
The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizabilityA A Kroon, P N Demacker, H A Kleinveld, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The Netherlands Journal of Medicine|July 1, 1997
LDL-cholesterol lowering and atherosclerosis--clinical benefit and possible mechanisms: an updateA A Kroon, A F Stalenhoef
Journal of Cardiovascular Pharmacology|September 10, 1998
Hypertension and the development of heart failureP W de Leeuw, A A Kroon
The Netherlands Journal of Medicine|January 8, 2004
Who should be taking the blood pressure?P W de Leeuw, A A Kroon
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
Fixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertensionP W de Leeuw, A A Kroon
Acta Clinica Belgica|January 30, 2004
Management of hypertensionP W de Leeuw, A A Kroon
Journal of Internal Medicine|December 1, 1991
N-acetylcysteine and serum concentrations of lipoprotein(a)A A Kroon, P N Demacker, A F Stalenhoef
Cardiologia (Rome, Italy)|November 22, 1997
Aggressive lipid lowering treatment in coronary atherosclerosisA F Stalenhoef, A A Kroon, W R Aengevaeren
Annals of Internal Medicine|December 15, 1996
Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery diseaseA A Kroon, W N van Asten, A F Stalenhoef
Nederlands Tijdschrift Voor Geneeskunde|April 12, 2008
[Practical questions related to self-measurement of blood pressure]W J Verberk, A A Kroon, P W de Leeuw
Atherosclerosis|October 19, 1999
The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizabilityA A Kroon, P N Demacker, H A Kleinveld, et al.
Pageof 6